Health Products

Apo-Topiramate (2013-09-10)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
JY2391
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
B. Apo-Topiramate, 100 mgTabletsDIN 02279630Topiramate, 100 mg
KF1436
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
C. Apo-Topiramate, 200 mgTabletsDIN 02279649Topiramate, 200 mg
KE4670
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
A. Apo-Topiramate, 25 mgTabletsDIN 02279614Topiramate, 25 mg

Introduction

Recalled Products

A. Apo-Topiramate, 25 mg

B. Apo-Topiramate, 100 mg

C. Apo-Topiramate, 200 mg

Reason

Lots may not meet the registered limit for sulfate during the shelf life of the product.

Depth of distribution

Wholesalers/Distributors - Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec, Saskatchewan.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime